Publication | Closed Access

Rifampicin: a new rifamycin. II. Laboratory studies on the antituberculous activity and preliminary clinical observations.

Antimicrobial SusceptibilityHealth SciencesAntibioticsMedicineTuberculosisAntituberculous ActivityAntibacterial AgentAntimicrobial ChemotherapyMicrobiologyAntimicrobial PharmacokineticsPharmacologyClinical MicrobiologyAntimicrobial ResistanceNew RifamycinLaboratory StudiesDrug Resistance